Chemical Engineering


A Generalizable Strategy for the 3D Printing of Hydrogels from Non-viscous Photocrosslinkable Inks. Advanced Materials, 2017, 29: 1604983. ABSL. Ouyang, C.B. Highley, W. Sun, J.A. Burdick


Kyle is an Assistant Professor in the Department of Chemical Engineering at the University of Virginia, and by courtesy, Biomedical Engineering and Neuroscience. He was previously a Ruth L. Kirschstein NIH NRSA postdoctoral scholar at Stanford University with Prof. Sarah Heilshorn in the department of Materials Science and Engineering. Kyle completed his Ph.D. and B.S. in Chemical Engineering from the University of Colorado, Boulder and the Missouri University of Science and Technology (Rolla, MO), respectively.


B.S. University of Illinois at Urbana-Champaign, 1999Ph.D. University of Delaware, 2006Post-Doc: University of Pennsylvania School of Medicine, 2006-2009

"We utilize synthetic biology and protein engineering to address emergent challenges across diverse areas such as sustainable production of green materials, advanced biomanufacturing, improving drug bioavailability and combating antimicrobial resistance."


A full list of publications is available via Google Scholar.


G.M. Geise, B.D. Freeman, D.R. Paul, "Fundamental water and salt transport properties of polymeric materials", Progress in Polymer Science, 39 (2014) 1-42.

G.M. Geise, H.B. Park, A.C. Sagle, B.D. Freeman, J.E. McGrath, "Water permeability and water/salt selectivity tradeoff in polymers for desalination", Journal of Membrane Science, 369 (2011) 130-138.


We are interested in developing new or improved catalytic materials by studying how the structure of a catalyst affects its performance in a chemical reaction.


We investigate the complex dynamic behavior of chemically reacting systems and its applications in fields from medicine to electrochemistry. 


Our research group focuses on the synthesis of well-defined nanoparticles, their dispersion into polymer solutions and melts, and their suspension rheology.


The sequencing of the human genome promises to provide numerous new proteins as drug targets and therapeutic agents. We are investigating several obstacles to the efficient commercialization of these delicate molecules. In addition, we are exploring protein misfolding relating to human disease.

Subscribe to RSS - Chemical Engineering